Spyglass Pharma, Inc. · NASDAQ:SGP
SANDS FRANK M. reported a 7.80% stake in Spyglass Pharma, Inc. (Schedule 13G)
Event Feb 6, 2026 · Filed Feb 13, 2026
SANDS FRANK M. reported a 7.80% stake in Spyglass Pharma, Inc., 2,500,012 shares, as a passive investor on Feb 6, 2026. Filed Feb 13, 2026 (Schedule 13G).
- Stake
- 7.80%
- Shares
- 2,500,012
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sands Capital Life Sciences Pulse Fund III (DE), L.P. | 1.30% | 420,797 |
| Sands Capital Life Sciences Pulse Fund III-Holdings, L.P. | 6.50% | 2,079,215 |
| Sands Capital Alternatives, LLC | 1.30% | 420,797 |
| SANDS FRANK M. | 7.80% | 2,500,012 |
Source
Related
- Spyglass Pharma, Inc.
- Sands Frank M.
- Spyglass Pharma, Inc. shareholders
- Schedule 13D · Ra Capital Management, L.P. · Feb 17, 2026
- Schedule 13G · Srinivas Akkaraju · Feb 17, 2026
- Schedule 13D · New Enterprise Associates 17, L.P. · Feb 13, 2026
- Schedule 13D · Gilde Healthcare Holding B.V. · Feb 13, 2026
- Schedule 13D · Vensana Capital I GP, LLC · Feb 10, 2026